Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

HEXO Celebrates Five Years, 200 Employees … and Growing!


Posted on: 16 Aug 18

GATINEAU, Quebec, Aug. 16, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (“HEXO” or the “Company”) (TSX:HEXO) is proud to announce that it has reached two milestones this week. The Company is celebrating its fifth anniversary and recently surpassed 200 employees.

The Company was incorporated in 2013 by co-founders Adam Miron and Sebastien St-Louis and is based in Masson-Angers, Quebec. Now listed on the TSX, HEXO has a market cap of more than $750 million.

To mark the two occasions, HEXO is hosting an all-staff summer BBQ this afternoon. Local dignitaries will also be in attendance: Mr. Alexandre Iracà, member of the Quebec National Assembly for Papineau; Mr. Marc Carrière, municipal councillor for the City of Gatineau; and Mr. Stephane Lauzon, member of the Canadian Parliament for Argenteuil—La Petite-Nation.

“We are proud of the team that we have built so far,” said Andree St-Cyr, HEXO’s Director of Human Resources.

“We have a diverse group of hard-working people who care about each other and the company. Over the coming weeks, months and years, we look forward to adding new people who share our team’s values and visions.”

HEXO is particularly interested in candidates who are looking to grow within the company and enjoy working in a fast paced environment. The Company is looking to fill new positions from entry level to senior management across many departments such as cultivation, processing, finance, marketing, and sales. HEXO is also seeking candidates to expand their information technology and product innovation departments.

HEXO is anticipating further expansion and plans to employ more than 500 people by the end of 2018. Interested candidates are advised to send their resumes to resume@hexo.com and consult the careers section of the website for available opportunities at www.thehydropothecary.com/careers.

About HEXO

HEXO creates and distributes innovative, easy-to-use and easy-to-understand products to serve the Canadian cannabis market. One of the country’s lowest-cost producers, HEXO is rapidly increasing its production capacity in the lead up to the adult-use cannabis market. The Company currently operates with over 310,000 sq. ft. of production capacity with construction on another 1,000,000 sq. ft. expansion set to be complete by year end. HEXO will serve the adult-use market under the HEXO brand, while continuing to serve its medical cannabis clients through the well-known Hydropothecary brand.  

Forward-Looking Information

This press release may contain forward-looking information that is based on certain assumptions and involves known and unknown risks and uncertainties and other factors that could cause actual events to differ materially from current assumptions and expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. A more complete discussion of the risks and uncertainties facing the Company appears in the Company’s Annual Information Form and continuous disclosure filings, which are available on SEDAR’s website at www.sedar.com. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements as a result of new information or future events, or for any other reason.

Neither the Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

Investor Relations:
Jennifer Smith
Manager of Financial Reporting and Investor Relations
1-866-438-8429
invest@HEXO.com
www.THCX.com

Media Relations:
Sarah Brown
sarah.brown@hexo.com

Director
Adam Miron
819-639-5498

GlobeNewswire
globenewswire.com

Last updated on: 16/08/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.